Barclays PLC Spectrum Pharmaceuticals Inc Transaction History

Barclays PLC

  • $288 Billion
  • Q1 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.7 - $1.4 $18,529 - $37,058
-26,470 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.63 - $1.59 $117,504 - $296,558
-186,515 Reduced 87.57%
26,470 $34,000
Q4 2021

Feb 14, 2022
BUY
$1.27 - $2.42 $101,639 - $193,675
80,031 Added 60.19%
212,985 $271,000
Q3 2021

Nov 09, 2021
SELL
$2.15 - $3.82 $89,063 - $158,243
-41,425 Reduced 23.76%
132,954 $290,000
Q2 2021

Aug 13, 2021
SELL
$2.89 - $4.45 $85,815 - $132,138
-29,694 Reduced 14.55%
174,379 $653,000
Q1 2021

May 13, 2021
SELL
$2.9 - $4.09 $45,878 - $64,703
-15,820 Reduced 7.19%
204,073 $665,000
Q4 2020

Feb 11, 2021
SELL
$3.38 - $5.14 $125,303 - $190,550
-37,072 Reduced 14.43%
219,893 $750,000
Q3 2020

Nov 12, 2020
BUY
$2.99 - $4.9 $241,499 - $395,768
80,769 Added 45.84%
256,965 $1.05 Million
Q2 2020

Aug 12, 2020
BUY
$2.11 - $3.38 $151,734 - $243,062
71,912 Added 68.96%
176,196 $596,000
Q1 2020

May 13, 2020
SELL
$1.83 - $3.45 $121,843 - $229,704
-66,581 Reduced 38.97%
104,284 $242,000
Q4 2019

Feb 10, 2020
SELL
$3.5 - $10.35 $247,961 - $733,256
-70,846 Reduced 29.31%
170,865 $622,000
Q3 2019

Nov 14, 2019
BUY
$7.03 - $9.7 $404,878 - $558,652
57,593 Added 31.28%
241,711 $2.01 Million
Q2 2019

Aug 14, 2019
BUY
$7.36 - $11.26 $540,974 - $827,632
73,502 Added 66.45%
184,118 $1.59 Million
Q1 2019

May 15, 2019
BUY
$9.08 - $11.84 $471,179 - $614,401
51,892 Added 88.37%
110,616 $1.18 Million
Q4 2018

Feb 14, 2019
SELL
$6.39 - $16.99 $633,191 - $1.68 Million
-99,091 Reduced 62.79%
58,724 $513,000
Q3 2018

Nov 14, 2018
BUY
$16.52 - $24.82 $731,290 - $1.1 Million
44,267 Added 38.99%
157,815 $2.65 Million
Q2 2018

Aug 14, 2018
SELL
$14.31 - $21.75 $13.8 Million - $21 Million
-965,493 Reduced 89.48%
113,548 $2.38 Million
Q1 2018

May 15, 2018
SELL
$16.09 - $23.07 $138,438 - $198,494
-8,604 Reduced 0.79%
1,079,041 $17.4 Million
Q4 2017

Feb 14, 2018
BUY
$13.36 - $20.73 $60,280 - $93,533
4,512 Added 0.42%
1,087,645 $20.6 Million
Q3 2017

Nov 14, 2017
BUY
$8.75 - $14.07 $9.48 Million - $15.2 Million
1,083,133
1,083,133 $15.2 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email